Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Inflammatory Bowel Diseases|April 25, 2006
Associations of allelic variants of the multidrug resistance gene (ABCB1 or MDR1) and inflammatory bowel disease and their effects on disease behavior: a case-control and meta-analysis studyClive M Onnie, Sheila A Fisher, Reenal Pattni, et al.
The Cochrane Database of Systematic Reviews|February 17, 2012
Stem cell treatment for acute myocardial infarctionDavid M Clifford, Sheila A Fisher, Susan J Brunskill, et al.
European Journal of Human Genetics : EJHG|September 11, 2008
Meta-analysis of genome-wide linkage studies across autoimmune diseasesPaola Forabosco, Emmanuelle Bouzigon, Mandy Y Ng, et al.
Human Molecular Genetics|February 21, 2004
Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairsDavid A van Heel, Sheila A Fisher, Andrew Kirby, et al.
The Cochrane Database of Systematic Reviews|May 9, 2018
Interventions for improving adherence to iron chelation therapy in people with sickle cell disease or thalassaemiaPatricia M Fortin, Sheila A Fisher, Karen V Madgwick, et al.
Nature Genetics|May 31, 2008
Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNALars G Fritsche, Thomas Loenhardt, Andreas Janssen, et al.
Journal of Critical Care|November 19, 2018
Safety and efficacy of iron therapy on reducing red blood cell transfusion requirements and treating anaemia in critically ill adults: A systematic review with meta-analysis and trial sequential analysisAkshay Shah, Sheila A Fisher, Henna Wong, et al.
Human Molecular Genetics|September 22, 2005
Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease riskAndrea Rivera, Sheila A Fisher, Lars G Fritsche, et al.
Human Mutation|January 12, 2007
Case-control genetic association study of fibulin-6 (FBLN6 or HMCN1) variants in age-related macular degeneration (AMD)Sheila A Fisher, Andrea Rivera, Lars G Fritsche, et al.
Plos One|June 2, 2012
Long-term effects of autologous bone marrow stem cell treatment in acute myocardial infarction: factors that may influence outcomesDavid M Clifford, Sheila A Fisher, Susan J Brunskill, et al.
Pageof 6